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Abstract
Ideal cardiovascular health is a recently defined construct by the American Heart Association 
(AHA) to promote cardiovascular disease reduction. Arterial stiffness is a major risk factor for 
cardiovascular disease. The extent to which the presence of multiple prevalent cardiovascular risk 
factors and health behaviors is associated with arterial stiffness is unknown. The aim of this study 
was to examine the association between the AHA construct of cardiovascular health and arterial 
stiffness, as indexed by pulse wave velocity and pulse pressure. The AHA health metrics, 
comprising of four health behaviors (smoking, body mass index, physical activity, and diet) and 
three health factors (total cholesterol, blood pressure, and fasting plasma glucose) were evaluated 
among 505 participants in the Maine-Syracuse Longitudinal Study. Outcome measures were 
carotid-femoral pulse wave velocity (PWV) and pulse pressure measured at 4 to 5-year follow-up. 
Better cardiovascular health, comprising both health factors and behaviors, was associated with 
lower arterial stiffness, as indexed by pulse wave velocity and pulse pressure. Those with at least 
five health metrics at ideal levels had significantly lower PWV (9.8 m/s) than those with two or 
less ideal health metrics (11.7 m/s) (P<0.001). This finding remained with the addition of 
demographic and PWV-related variables (P=0.004).
Keywords
arterial stiffness; pulse wave velocity; cardiovascular health
Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
Corresponding author: Georgina Crichton, PhD, CRP-Santé, Centre d’Etudes en Santé, 1A rue Thomas Edison, L-1445 Strassen, 
Luxembourg, Tel.: +352 26 970 394; Fax: +352 26 970 719., georgina.crichton@unisa.edu.au. 
CONFLICT OF INTEREST
The authors declare no conflict of interest.
Supplementary information is available at the Journal of Human Hypertension website (http://www.nature.com/jhh/index.html).
HHS Public Access
Author manuscript
J Hum Hypertens. Author manuscript; available in PMC 2015 January 01.
Published in final edited form as:
J Hum Hypertens. 2014 July ; 28(7): 444–449. doi:10.1038/jhh.2013.131.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
INTRODUCTION
Arterial stiffness is higher in persons with diabetes mellitus, obesity, and other 
cardiovascular risk factors and increases with blood pressure and age.1, 2 It is a major risk 
factor for myocardial infarction, stroke, end stage renal disease and other cardiovascular 
diseases (CVD).3–6 Traditionally, blood pressure (BP) is measured non-invasively by 
determining the pressure (mm/Hg) in the brachial artery in the upper arm and arterial 
stiffness is indirectly assessed by way of pulse pressure (PP) defined as systolic BP (SBP) 
minus diastolic BP (DBP).
However, there is increasing recognition that measures of central arterial function are more 
valuable predictors of vascular health outcomes than traditional BP, and pulse wave velocity 
(PWV) is now considered the gold standard non-invasive method for measuring aortic 
stiffness, and more generally arterial stiffness.7
While various indices of arterial stiffness, including PWV, have been related to risk factors 
for CVD, there have been few, if any, studies that have related positive health factors and 
behaviors to PWV. Crichton, Elias, Dore, Abhayaratna, and Robbins8 found that dairy 
consumption in a relatively healthy community-based population was related to lower PWV, 
PP and SBP, but not to DBP. This study raises the question as to whether positive health 
behaviors are related to lower levels of PWV and, by inference, lower levels of arterial 
stiffness. This can be addressed by comparing PWV values for persons with constellations 
of cardiovascular risk factors that are associated with reduced cardiovascular morbidity and 
mortality and those that place one at higher risk.
The American Heart Association (AHA) has defined ideal cardiovascular health as the 
presence of four health behaviors (non-smoking, regular physical activity at goal levels, 
body mass index (BMI) <25 kg/m2, and diet consistent with national recommendations) and 
three health factors (total cholesterol <200 mg/dL, BP <120/<80 mm Hg, and fasting blood 
glucose <100 mg/dL) at ideal level.9 This definition of cardiovascular health was designed 
to facilitate the monitoring of CVD and the promotion of substantial disease reduction by 
2020. Two years after its introduction, Ford, Greenlund and Hong10 found that the number 
of ideal cardiovascular health factors and behaviors was a strong predictor of all-cause 
mortality and diseases of the circulatory system. Intakes of omega-3 fish oils, soy 
isoflavones, and fermented milk products containing bioactive peptides have been related to 
lower levels of arterial stiffness.11 Thus positive health behaviors do appear to play a role in 
lowering arterial stiffness. However, it is unknown whether the combined influence of 
multiple risk factors and behaviors is associated with arterial stiffness. To our knowledge 
this hypothesis has not been tested using a constellation of health factors to categorize 
individuals with respect to gradations of ideal cardiovascular health. We hypothesized that a 
higher number of cardiovascular health factors and behaviors at ideal levels, as defined by 
the AHA,9 would be related to lower levels of aortic stiffness as indexed by PWV and PP.
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MATERIALS AND METHODS
Study design and participants
Data were obtained from the Maine Syracuse Longitudinal Study (MSLS) data set.12 
Beginning in 1974, MSLS participants were recruited from Syracuse, New York and 
surrounding counties for studies of BP and cognitive performance. There were no exclusions 
at recruitment other than institutionalization, diagnosed psychiatric disorder and treatment 
for diagnosed alcoholism. Extensive data on risk factors for CVD were collected for the first 
time at wave 6 (2001–2006) and PWV data were obtained for the first time at wave 7 (2006–
2010). This allowed for a prospective design in which cardiovascular risk factors at wave 6 
were used to predict PWV at wave 7. Mean time between waves 6 and 7 was 4.68 years (s.d. 
= 0.61). Eight-hundred twenty two subjects were invited back to the laboratory for testing at 
wave 7. Six-hundred nine participants returned and completed PWV data collection. 
Participants were excluded for the following reasons: missing baseline data for health 
variables (n = 61), acute stroke at baseline (n = 28), probable dementia at baseline (n = 8), 
undertaking renal dialysis treatment at baseline (n = 5), inability to read English (n = 1), and 
prior alcohol abuse (n = 1), leaving a final sample of 505 people. Acute stroke was defined 
as a focal neurological deficit persisting for >24 hours and probable dementia was defined 
by cognitive measures, medical records and a multidisciplinary dementia review using the 
National Institute of Neurological Diseases and Communicative Diseases and Stroke/ 
Alzheimer's Disease and Related Disorders (NINCDS-ADRDA) criteria.13 The University 
of Maine Institutional Review Board approved this study and informed consent was 
obtained from all participants.
Procedure
Except for assessment of PWV at wave 7, procedures were identical at waves 6 and 7. A 
blood sample was obtained following a fast from midnight. Anthropometric measures and 
BP were taken after a light breakfast including decaffeinated tea or coffee. Body weight was 
measured with participants wearing light clothing to the nearest 0.1 kg, and height was 
measured with a vertical ruler to the nearest 0.1 cm. Brachial artery pressure was assessed at 
waves 6 and 7 using the traditional pressure-cuff method (Critikon Dinamap Pro Care 100, 
oscillometeric method). After 10 minutes of supine rest, five measurements were taken in 
the supine, sitting and standing positions, with a 5-minute rest between each set of measures. 
After reclining for 10 minutes, 5 additional BP measures in the supine position were taken 
and the mean of these 5 measurements provided the brachial supine BP values for the 
SphygmoCor® system protocol.
Information assessed via clinical interview or questionnaire included the Nurses’ Health 
Study Activity Questionnaire,14 the Nutrition and Health Questionnaire,15, 16 the Center for 
Epidemiological Studies Depression Scale (CES-D),17 and the self-rating of health.
The Independent Variable: Cardiovascular Health
Cardiovascular Health component measures were assessed as follows. Standard assay 
methods were employed18 to obtain the health factor measures of total cholesterol and 
fasting plasma glucose, as well as high density lipoprotein (HDL) and low density 
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lipoprotein (LDL) cholesterols, and triglycerides. SBP and DBP were calculated by 
averaging the fifteen BP measurements. With regard to the health behaviors, BMI was 
calculated as weight in kilograms divided by height in meters squared. Physical activity was 
measured with the Nurses’ Health Study Activity Questionnaire.14 From this validated 
measure, the time spent engaging in various physical activities was multiplied by the MET 
value for each activity19 to obtain MET-hours per week, and then and summed to give total 
MET-hours per week. Smoking status (never, former, current) was based on self-report from 
the Nutrition and Health Questionnaire, as was dietary intake.15, 16 Participants are required 
to stipulate how frequently they consume a list of foods, with six response options (never, 
seldom, 1 time per week, 2–4 times per week, 5–6 times per week, ≥1 time per day). Portion 
or serving sizes are not stipulated; the totals are an estimate of intake in terms of times per 
day. For the diet metric of the Cardiovascular Health index, a Recommended Food Score 
(RFS)20 and a non-Recommended Food Score (non-RFS)21 were calculated. These scores 
were used in place of the AHA healthy diet metric for two reasons: 1) due to the availability 
of dietary data available from the questionnaires used, and 2) to capture a more detailed 
measure of dietary intakes with regard to the 2010 Dietary Guidelines for Americans.22 The 
RFS included 23 items: four types of fruit (fresh, dried, stewed/tinned, pure fruit juice), 
eight types of vegetables and legumes (peas, baked beans, lentils and dried beans, tomatoes, 
carrots, green vegetables, other cooked vegetables, salad/raw vegetables), five types of 
wholegrain cereal products (brown bread, whole wheat cereal, bran cereal, hot oat cereal, 
museli), two types of fish (fatty fish and other fish), two low fat milk products (semi-
skimmed or skim milk), nuts and seeds, and olive oil. These items are similar to those used 
previously.20, 23 Consumption of any of the recommended foods at least once per week was 
assigned 1 point, otherwise 0 points if consumed less often.20 A total RFS out of 23 was 
calculated, with a high score indicating a higher consumption of recommended food items.
The non-RFS included 15 items: processed meats (combined bacon/meat pies/sausage), four 
whole-fat dairy products (milk, butter, hard margarine, combined cream/ice-cream), two 
types of refined grains (white bread, sweet rolls), solid fats/added sugars group (pizza, 
french fries, combined cakes/puddings/pies, carbonated soft drinks, combined fruit drinks/
sports drinks, sweets, added sugar to drinks or cereal), and alcohol (males > 14 standard 
drinks/week, females > 7 standard drinks/week). A score of 1 was assigned for consumption 
of non-recommended foods at least 2 to 4 times per week; otherwise 0 points were assigned 
if consumed less often than this.23, 24 A total non-RFS out of 15 was calculated, with a 
higher value indicating a higher consumption of non-recommended food items.
The AHA definitions9 were used to determine ideal levels of cardiovascular health for 
smoking, BMI, physical activity, BP, total cholesterol, and fasting blood glucose. For each 
component, participants were given a score of 1 if they met the ideal AHA criterion, 
otherwise 0 points were assigned. The diet metric was split into two components (RFS and 
non-RFS as described above). The highest 15% of RFS (≥14/23) and the lowest ≤15% of the 
non-RFS ( 1/15) were given a score of 1. A total Cardiovascular Health Score (CHS) was 
calculated ranging from 0 (no cardiovascular health components at ideal levels) to 8 (all 
cardiovascular health components at ideal levels), and then categorized into low (score of 0–
2), medium (3–4) or high (5–8) cardiovascular health. The scores were categorized into 
these three groups to create the most equal groups for comparison.
Crichton et al. Page 4
J Hum Hypertens. Author manuscript; available in PMC 2015 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
The Dependent Variable: PWV
Following BP five supine measurement as described above, PWV was assessed non-
invasively in the supine position using the SphygmoCor® system (AtCor Medical, Sydney, 
Australia). Electrocardiogram-gated carotid and femoral waveforms were recorded using 
applanation tonometry. Carotid-femoral path length was measured as the difference between 
the surface distances joining: i) the suprasternal notch, the umbilicus and the femoral pulse, 
and ii) the suprasternal notch and the carotid pulse, measured in meters. Carotid-femoral 
transit time was estimated in 8–10 sequential femoral and carotid waveforms as the average 
time difference between the onset of the femoral and carotid waveforms. The foot of the 
pulse wave was identified using the intersecting tangent method. PWV was calculated as the 
carotid-femoral path length in meters divided by the carotid-femoral transit time in seconds. 
This is an established, widely employed, non-invasive and reproducible method to determine 
arterial stiffness.7 The coefficient of variation (1.79%) for serial measurements of PWV in 
our laboratory indicates high reproducibility of the PWV measurements.
Covariates
The data collected for covariance analyses and statistical adjustment, or to more thoroughly 
characterize the sample, are summarized as sample-descriptive data in the results section 
with units of measurement. Standard assays and diagnostic criteria were used and are fully 
described in a previous study.25 Self-report variables were as follows: education level 
(years), alcohol consumption (grams per week), cigarette smoking (number per week), and 
self-rated health (ranging from 1= very poor, to 5 = excellent). Depressive symptoms were 
measured using the CES-D.17 Prevalent CVD was defined by the self-reported presence of 
coronary artery disease, myocardial infarction, congestive heart failure, transient ischemic 
attack, or angina pectoris, and confirmed by medical records. Obesity was defined as a BMI 
of 30 kg/m2 or above. Waist circumference was measured using a non-extendable tape at the 
level of the iliac crest. Diabetes mellitus was defined as treatment with insulin, oral anti 
hypoglycemic diabetic agents, or by fasting glucose level of ≥126 mg/dl. Hypertension was 
defined as treatment for hypertension or a BP of ≥140/90.
Statistical Analysis
For the primary analysis, the predictor, the covariates in the basic model and self-rated 
health were based on wave 6 data (prospectively) and heart rate, height, weight, and mean 
arterial pressure (MAP) were taken from wave 7 as it is essential that they be taken at the 
time of PWV and PP assessment. After eliminating CVD variables unrelated to both PWV 
and the CHS, the following models were employed to adjust for confounding with the CHS 
in the analysis:
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Preliminary analyses indicated a non-significant Age x CHS interaction (P=0.73) and a non-
significant Sex x CHS interaction (P=0.32); consequently these interaction terms were not 
employed in the final covariate models. Three categories of cardiovascular health were 
formed based on the number of ideal components that were observed: low (CHS 0–2), 
medium (CHS 3–4), and high (CHS 5–8). Analysis of variance (SPSS) was employed to 
compare mean values for the groups. Linear trend analyses across values for the three CHS 
groups were performed when the omnibus test was statistically significant at alpha=0.05. 
Distributional requirements were met.
In order to examine standardized regression coefficients expressing relations between CHS 
and PWV mixed categorical and continuous regression analyses were performed using the 
linear regression feature of SPSS.
RESULTS
Table 1 displays descriptive data for the demographic, risk factor and health variables 
stratified by CHS group. The majority of variables shown were related to the CHS 
classifications. Height (P=0.31), alcohol consumption (P=0.90), and prevalence of CVD 
were clearly unrelated (P=0.87). The constituent variables of the CHS, characterized in 
Table 1 as cardiovascular health components, were related to PWV in linear regression 
analyses with each variable controlled for the others. Standardized regression coefficients 
indicated that SBP (β = 0.610, P< 0.001) and glucose (β=0.186, P<0.001) showed the 
highest positive relations with PWV in the CHS; the next highest magnitude of positive 
relations was observed for total cholesterol (β=0.078, P< 0.05), and the lowest for BMI (β= 
0.003, P= 0.94). These data are shown in Supplementary Table 1. Given that the CHS 
requires each of these variables, none were removed from the calculation of the CHS for the 
primary analyses.
Table 2 displays PWV (m/s) mean, P, and model R2 values for the three CHS groups and 
Figure 1 shows mean PWV according to CHS group (fully extended model). The omnibus 
comparisons among PWV means for the three CHS groups, and the tests of linear trend 
across the three PWV means, were all statistically significant for all three covariate models 
(P<0.001). Model R2 values indicate that the least gain in prediction was obtained by adding 
self-reported health to model 1 and model 2. Quadratic tends were not significant when 
adjusted for linear trend, but pair-wise comparisons of differences among means indicated 
that no differences were seen for the medium and high CHS groups. PWV values were 
significantly lower for the highest CHS group than for the low group (P values <0.05).
It could be argued that the presence of SBP and DBP in the CHS biased our results toward 
the positive in relation to PWV. However, we controlled for MAP in model 2, and we 
obtained the same results when we omitted SBP and DBP values from calculation of the 
CHS (data not shown).
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Linear regression analyses with categorical and continuous variables were done in order to 
examine the control variables in the model that were most strongly related to PWV when 
each was adjusted for the other. Standardized regression coefficients indicated that age (β 
=0.560, P<0.001), MAP (β =0.172, P<0.001), weight (β =0.132, P=0.003) and self-reported 
health (β =−0.94, P=0.01) exhibited the higher magnitude of relations with PWV; ethnicity 
(β = 0.035, P=0.34), gender (0.017, P=0.73), education (β =0.008, P=0.82) exhibited the 
lowest.
Given its traditional use as an index of arterial stiffness, analyses were repeated with PP. 
These data are shown in Supplementary Table 2; the results were similar to those obtained 
with PWV. The omnibus test and the linear regression analysis indicated significant 
differences among the CHS groups as for PWV.
Linear regression analyses using the CHS as a continuous variable yielded the same results 
for both PWV and PP, with regard to findings of significant linear and no quadratic trends 
(for all models). The same results were also obtained in sensitivity analyses replacing height 
and weight with waist circumference and then BMI.
There was no significant change in CHS from wave 6 to 7. Lipids and cigarette smoking 
were associated with significant but relatively minor changes (decreases) but these changes 
were unrelated to PWV. Diastolic BP showed an average rise of 7 mm Hg (s.e.=0.37, 
P<0.001). Each 1 mm Hg rise in diastolic BP (wave 6 to 7) was related to a 0.03 increment 
in level of PWV at wave 7 (b=0.03, P=0.03), or an estimated 0.21 increment for a 7 mmHg 
rise.
The CHS was unrelated to CVD prevalence at wave 6, however prevalence was very low 
(9.5%). The incidence of CVD (with any category resulting in a yes score for CVD) was 4 
percent (20 new cases) between wave 6 and 7. All 20 individuals that developed CVD had a 
CHS of 5 or less (lower score indicating poorer cardiovascular health). New cases of CVD 
at wave 7 also had a higher mean PWV (12.7 m/s) than those who did not change between 
waves (PWV of 10.5 m/s) (P=0.001, data not shown).
Attrition
In order to evaluate the effects of attrition on the results, CHS and health variable values for 
those who were participants at both wave 6 and wave 7 were compared with values for 
participants who did not return for wave 7 testing. Those who dropped out of the study were 
older, exhibited more depressive symptoms, higher SBP and DBP, lower HDL-cholesterol 
and lower self-rated health, and CHS (all P<0.05, data not shown). There was no significant 
difference in the rate of attrition between the three CHS groups (P=0.08, data not shown).
DISCUSSION
In this prospective study, PWV decreased significantly in a linear fashion across increasing 
CHS categories with full adjustment for demographic and PWV-related variables, and self-
rated health. Those with a higher number of ideal cardiovascular health metrics (5 or more) 
had significantly lower PWV than those with a low number of metrics at ideal levels (2 or 
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less). The findings were the same for PP. These findings are consistent with our hypothesis 
that increasingly higher CHS (decreasing cardiovascular risk) would be associated with 
lower PWV. Those with a medium CHS also had significantly lower PWV than the low 
CHS group.
These findings were the same for all covariate models. We adjusted for all CVD risk factors 
in the study that were related both to PWV and CHS. Self-rated health was an important 
control that attenuated but did not eliminate statistically significant results obtained with the 
more objectively scored CHS. Self-rated health has been shown to add value to risk 
prediction models for cardiovascular outcomes comprising traditional risk factors,26 and for 
mortality risk.27 In the present study, CHS was a stronger predictor of PWV than self-rated 
health.
To our knowledge the present study is the first to relate cardiovascular health as defined by 
the AHA9 to PWV. The Coronary Artery Risk Development in Young Adults study 
(CARDIA) is the only published longitudinal study that we are aware of in which the 
association between ideal cardiovascular health and cognitive function was investigated.28 
Persons with fewer ideal health metrics exhibited lower levels of psychomotor speed, 
executive function and verbal memory in midlife. As higher PWV is related to lower 
cognitive performance29, 30 and dementia,31 PWV could be an important mediator between 
cardiovascular health status and cognitive performance, a hypothesis that can be investigated 
in future studies using path analysis or structural equation modelling methods.
Comparisons of our data with other studies relating risk factors, good or bad, are important 
in terms of the population or clinical importance of the magnitude of the effects observed. 
With adjustment for the most extensive set of covariates, the low group in the present study 
had a PWV value of 11.3 m/s and the middle group a value of 10.3 m/s. In published 
reference group data for PWV for the MSLS sample1 this amount of difference (1 m/s) was 
seen between 50 to 59 year old and 60 to 69 year old individuals with essential hypertension, 
i.e. 9.3 m/s (s.d.=1.5) and 10.3 m/s (s.d.=2.3). In a recent study with data from the MSLS,8 
adjusting for demographics and cardiovascular risk factors, people who seldom or never 
consumed dairy exhibited a mean 1.0 m/s lower PWV value relative to those that consumed 
dairy at least 5 to 6 times per week. Although a 1 m/s difference in PWV might be 
considered as modest with respect to arterial stiffness in an individual, this magnitude of 
difference is most certainly important from a population risk perspective. In a recent meta-
analysis it was estimated that for every 1 m/s increase in PWV there were age-, sex- and 
cardiovascular risk factor adjusted increases of 14%, 15% and 15% in total cerebrovascular 
events, CVD mortality and all-cause mortality in general.6
The presence of SBP and DBP in the CHS could bias results in the positive direction for 
PWV in relation to CHS. However, we controlled for MAP in our regression models and, 
more importantly, we dealt with this issue by deleting the BP variables from the CHS and 
our findings with the full CHS were replicated. While it is true that cardiovascular risk 
factors, individually and in combination, e.g. diabetes and BP1, 2, 32 have been related to 
higher PWV, we feel the CHS is potentially valuable in monitoring patients because it 
relates a constellation of risk factors and health behaviors to PWV and thus does offer the 
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possibility, based on patient history, to evaluate the likelihood of higher levels of arterial 
stiffness. Obviously studies, including trials, in which decreasing risk and improving health 
behaviors are related to PWV and PP are an important next step in research should other 
studies using the AHA ideal cardiovascular health construct replicate our findings.
Some limitations of the current study must be acknowledged. The study was prospective, the 
cardiovascular health data were gathered, on average 4.8 years prior to PWV, however the 
study was not longitudinal as we only had one measurement of PWV. Studies with 
longitudinal follow-up of PWV are important.
There may also have been an underestimation of the association between cardiovascular 
health and PWV because the participants who did not return for wave 7 PWV assessment 
were older, exhibited more depressive symptoms, higher SBP and DBP, lower HDL-
cholesterol and lower self-rated health. As with most studies, smoking, diet and physical 
activity data were based on participant self-report.
Strengths of the study include a community-based sample, extensive data on cardiovascular 
risk factors enabling the control of potential confounding factors, the adjustment of findings 
for self-rated health, the use of two dietary metrics to measure adherence to the current 
national dietary recommendations, the inclusion of adults with a low prevalence of CVD 
spanning a wide age, and use of PWV as the primary indirect gold- standard measure of 
arterial stiffness. The constuct of cardiovascular health as defined by the AHA has not been 
examined in relation to arterial stiffness, or PWV before. The calculation of the CHS, with 
an expanded diet metric compared to that defined by the AHA, as an indicator of 
cardiovascular health is new. Therefore the findings of this study are novel in that they relate 
an indicator of cardiovascular health, ie. not cardiovascular disease, including lifestyle 
behaviors such as smoking, physical activity and diet, to arterial stiffness as indexed by 
PWV.
In conclusion, having more cardiovascular health metrics at ideal levels (indicated by a high 
CHS) is related to lower levels of PWV and, by inference from PWV, lower stiffness of the 
coronary arteries.33 However, PWV did not differ significantly between those with a high 
CHS (5–8 ideal health metrics) and those with a medium score (3–4 ideal health metrics). 
Thus improvements in PWV values reach an asymptotic level short of ideal on all health 
behaviors and factors. The literature identifies several promising avenues involving diet, the 
facilitation of physical activity and weight loss, which may impact directly upon arterial 
stiffness.8, 34, 35 We hope our findings with the CHS will be a stimulus to longitudinal 
studies using this construct and eventually controlled clinical trials relating effective 
management of CVD risk factors, lifestyle variables, and nutrition to arterial stiffness.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Summary Table
What is known about this topic
• Arterial stiffness is a major risk factor for cardiovascular disease.
• Less is known about the extent to which multiple cardiovascular risk factors and health behaviors 
are associated with arterial stiffness.
What this study adds
• Better cardiovascular health is related to lower arterial stiffness, as indexed by pulse wave velocity, 
with adjustment for demographic and clinical factors.
• Studies with longitudinal measurement of pulse wave velocity and controlled clinical trials are 
warranted to further explore this association.
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Figure 1. 
Mean pulse wave velocity according to Cardiovascular Health Score. Error bars are standard 
error of the mean. Data is for fully adjusted model (controlling for age, education, gender, 
ethnicity, height, weight, heart rate, mean arterial pressure, self-rated health).
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